Welcome to my blog :)

rss

Wednesday, July 3, 2013

Ayurveda the divine science of life -18
















































Ayurveda the divine science of life






  PART 2: A¯ yurvedic materia medica

Botany: Man.d.
u¯kaparn.
ı¯ is a slender herbaceous
creeping perennial, with long stems, rooting at the
nodes. The leaves are obicularly reniform, crenate, on
long petioles. The small flowers are white, pink or purple,
borne in fascicled umbels, giving rise to a fleshy
compressed fruit with two mericarps (Kirtikar & Basu
1935, Warrier et al 1994).
Part used: Leaves.
Dravygun. a:
Rasa: tikta, kat.u
Vipa¯ka: kat.u
Vı¯rya: ´sita
Karma: dı ¯pana, jvaraghna, raktaprasa¯dana,
mu¯travirecana, kus.t.
aghna, hr . daya, medhya, rasa¯yana.
Prabha¯va: also called Bra¯hmı ¯ (consort of Brahma¯)
because it aids in the development of Brahman, the
Supreme Reality, strengthening nervous function,
and promoting longevity, intelligence and memory
(Dash 1991, Dash & Junius 1983, Frawley & Lad
1986, Srikanthamurthy 1994, 2001, Warrier et al
1994).
Constituents: Man.d.
u¯kaparn.
ı¯ contains a variety
of constituents of which the triterpenoids have
attracted the most attention from researchers. These
include asiaticoside A and B, madecassoside,
braminoside, brahmiside, brahminoside, thankuniside,
isothankuniside, as well as triterpene acids such
as asiatic acid, 6-hydroxy asiatic acid, madecassic
acid, madasiatic acid, brahmic acid, isobrahmic acid,
betulinic acid and isothankunic acid. Man.d.
u¯kaparn.
ı¯
also contains flavones, including quercitin,
kaempferol and astragalin, the alkaloid hydrocotylin,
and phytosterols stigmasterol and sitosterol. The fresh
and recently dried plant contains an essential oil
comprising, primarily, sesquiterpenoids such as
-caryophyllene, -humulene and germacrene.
Additional constituents include tannins, amino acids,
B-complex vitamins and a resin (Heinerman 1984,
Williamson 2002, Yoganarasimhan 2000).
Medical research:
In vitro: neuroprotective (Mook-Jung et al 1999),
antitumuor (Babu et al 1995, Lin et al 1972).
In vivo: nootropic, anxiolytic (Leung & Foster
1996); GABA-nergic (Chatterjee et al 1992);
antimicrobial (Oliver-Bever 1986), CNS-depressant
(Ramaswamy et al 1970); antiulcer (Chatterjee et al
1992); antioxidant (Shukla et al 1999b); antiinflammatory
(Chen et al 1999); vulnerary
(Maquart et al 1999, Shukla et al 1999a, Suguna
et al 1996).
Human trials: Man.d.
u¯kaparn.
ı¯ promoted significant
improvements in cooperation, memory,
concentration, attention, vocabulary and social
adjustment in mentally challenged children,
compared to placebo (Appa Rao 1973);
Man.d.
u¯kaparn.
ı¯ significantly reduced the number
of circulating endothelial cells asiatica in patients
with post-phlebitic syndrome (Montecchio et al
1991) and significantly and safely promoted
improvement in patients with chronic venous
hypertensive microangiopathy (Cesarone et al
1994). Man.d.
u¯kaparn.
ı¯ was found to significantly
reduce ankle oedema and foot swelling, and
improve capillary filtration rate and microcirculatory
parameters in patients with venous insufficiency
(Cesarone et al 1992). A titrated extract of
Man.d.
u¯kaparn.
ı¯ promoted clinical improvement
in 5 of 12 patients with chronic hepatic disorders
(Darnis et al 1979). Man.d.
u¯kaparn.
ı¯ was efficacious
in the treatment of chronic or subchronic
systemic scleroderma with limited skin involvement,
and in progressive and/or advanced focal
Man.d.
u¯kaparn.
ı¯, ‘frog-leaved’
BOTANICAL NAME: Centella asiatica, Apiaceae
OTHER NAMES: Bra¯hmı¯, ‘consort of Brahma¯‘, Brahma¯man.
d.
uki, ‘frog-leaved
Brahma¯‘ (S); Bemgsag (H); Vallarai (T); Indian Penny-wort (E); Luei Gong
Gen (C); ‘Gotu Kola’ is derived from the Sinhala name
Man.d.
u¯kaparn.
ı¯, ‘frog-leaved’ 241
scleroderma (Guseva et al 1998). In the treatment
of keloids madecassol (asiaticoside)
extracted from Man.d.
u¯kaparn.
ı¯ compared
favourably with compression bandaging, and provided
more lasting results than either intralesional
cortisone or radiation therapy (Bosse et al
1979); a topical extract of Centella asiatica was
found to be useful in Pseudofolliculitis barbae
(razor bumps) when used as a shaving lubricant
(Spencer 1985).
Toxicity: No relevant data found.
Indications: Gastric ulceration and inflammation,
dysentery, jaundice, hepatitis, fever, bronchitis,
alopecia, eczema, psoriasis, leprous ulcers, venereal
diseases, burns, anxiety, poor memory, ADD/ADHD,
senility, Alzheimer’s disease, epilepsy, chronic
fatigue, premature aging, hypertension, anaemia,
diabetes, oedema, varicosities, phlebitis, venous
insufficiency, immunodeficiency, autoimmune disorders,
cancer.
Contraindications: A water-soluble fraction of
Centella asiatica was reported to inhibit hepatic
enzymes responsible for barbiturate metabolism
(Leung & Foster 1996), and has been found to have
a GABAnergic activity (Chatterjee et al 1992).
Man.d.
u¯kaparn.
ı¯ is thus contraindicated with the concurrent
use of drugs such as benzodiazepines, barbituates
or antiepileptics. Contact dermatitis has been
reported in some patients using preparations of fresh
or dried parts of the plant (Eun & Lee 1985). Although
the triterpene constituents have shown to lack
any kind of teratogenic effect (Bosse et al 1979),
relaxation of the rat uterus has been documented
for brahmoside and brahminoside, and therefore
Man.d.
u¯kaparn.
ı¯ is thus avoided in pregnancy
(Ramaswamy et al 1970). Hyperglycaemic and hypercholesterolaemic
effects have been reported for asiaticoside
in humans (Newall et al 1996), and caution
should be exercised with the concomitant use of
hypolipidaemic and hypoglycaemic therapies.
Frawley & Lad (1986) report that high doses of
Man.d.
u¯kaparn.ı¯ may cause a loss of consciousness
and headaches and that they may aggravate pruritis.
The majority of A¯ yurvedic texts tend to indicate that
Man.d.u¯kaparn.
ı¯ is contraindicated in va¯ttika conditions
(Warrier et al 1995).
Medicinal uses: Man.d.
u¯kaparn.
ı¯ is a common
green vegetable throughout Southeast Asia, from
India to the Phillipines, sometimes eaten raw as a
side dish, or prepared as a juice. It is said to be a
favourite food of elephants in Sri Lanka. Modern clinical
research has supported many of the time-honoured
properties attributed to Man.d.
u¯kaparn.
ı¯. Plant
geneticists have recently termed Man.d.
u¯kaparn.
ı¯ as
an ‘araliaceous hydrocotyloid’ (Downie et al 2000),
for although it is a member of the Apiaceae, it bears
many similarities both botanically and in therapeutic
action with other genera of the Araliaceae, such as
Ginseng (Panax ginseng). For internal administration
the fresh plant is considered best, either as a juice, or
more recently, as a fresh plant tincture. Dried plant
preparations are used in A¯ yurveda and should not be
considered as useless; however care should be taken
to carefully source the herb as Man.d.
u¯kaparn.
ı¯
grows quite well along the edges of rivers and sewer
outfalls and could be contaminated with heavy metals,
faecal coliforms or parasites. Man.d.
u¯kaparn.
ı¯ is a
useful treatment in a range of mental and cerebrovascular
conditions including epilepsy, stroke,
dementia, memory loss, poor concentration, and
attention deficit disorder. Some texts state that
Man.d.
u¯kaparn.ı¯ is the same as Bra¯hmı¯ (Bacopa monniera)
in action, some even suggesting that they are
one and the same. They are, however, different plants
with a different range of activities, but both are
active as agents to enhance mental function.
Generally speaking, Man.d.
u¯kaparn.
ı¯ is used in cognitive
dysfunction where pitta is the predominant
dos.a, best used as the fresh juice, 25 mL twice daily.
In skin conditions such as psoriasis and eczema,
benefit can be obtained by using Man.d.
u¯kaparn.
ı¯
with hepatics such as Bhr.n . gara¯ja, Mañjis.t.
ha¯,
Da¯ruharidra¯ and Yellowdock (Rumex crispus).
Man.d.
u¯kaparn.
ı¯ may also be used topically in salves
and balms to treat chapped lips, herpetic lesions, leprosy,
scrofula, seborrheic dermatitis, ‘dish pan’
hands, eczema, psoriasis and insect bites and stings.
As an alternative to antibiotics, Man.d.
u¯kaparn.
ı¯
could be taken internally with Kat.uka and
Bhu¯nimba, or Western herbs such as Goldenseal
(Hydrastis canadensis root) and Purple Coneflower
(Echinacea spp.) in the treatment of infectious conditions.
For wounds Man.d.
u¯kaparn.
ı¯ can be combined
with Comfrey (Symphytum officinalis root), applied
topically and taken internally to speed healing and
242 PART 2: A¯ yurvedic materia medica
recovery. Man.d.
u¯kaparn.
ı¯, along with other
immunomodulants such as Huang qi (Astragalus
membranaceus) and A´svagandha¯, should be considered
an adjunct in the treatment of immunodeficiency
diseases. The As.t.
a¯ñga Hr.
daya mentions the
usefulness of Man.d.
u¯kaparn.
ı¯ in the treatment of
sannipa¯taja udara (abdominal enlargement in
which all three dos.as are active), after purgative
therapies have been initiated, taken as the fresh juice
for a period of a month (Srikanthamurthy 1995).
Dosage:
Cu¯rn.
a: 3–10 g b.i.d.–t.i.d.
Svarasa: 25 mL b.i.d.–t.i.d.
Pha¯n.t.
a: 30–120 mL b.i.d.–t.i.d.
Tincture: fresh plant 1:2, 95% alcohol; dry plant
1:3, 50% alcohol, 1–5 mL b.i.d.–t.i.d.
Ghr. ta: 2 gtt. s.d. taken as nasya for nervous
disorders.
Taila: ad lib. in abhyan . ga etc. for nervous system
disorders.
REFERENCES
Appa Rao MVR, Srinivasan K, Rao KT 1973 The effect of
Mandookaparni (Centella asiatica) on the general mental ability
(medhya) of mentally retarded children. Journal of Indian
Medicine 8:9–16
Babu TD, Kuttan G, Padikkala J 1995 Cytotoxic and antitumor properties
of certain taxa of Umbelliferae with special reference to
Centella asiatica (L.) Urban. Journal of Ethnopharmacology
48(1):53–57
Bosse JP, Papillon J, Frenette G et al 1979 Clinical study of a
new antikeloid agent. Annals of Plastic Surgery 3(1):
13–21
Cesarone MR, Laurora G, De Sanctis MT, Belcaro G 1992 Activity of
Centella asiatica in venous insufficiency. Minerva
Cardioangiologica 40(4):137–143
Cesarone MR, Laurora G, De Sanctis MT et al 1994 The microcirculatory
activity of Centella asiatica in venous insufficiency.
A double-blind study. Minerva Cardioangiologica
42(6):299–304
Chatterjee TK, Cakraborty A, Pathak M, Sengupta GC 1992 Effects
of plant extract Centella asiatica (Linn.) on cold restraint stress
ulcer in rats. Indian Journal of Experimental Biology
30(10):889–891
Chen YJ, Dai YS, Chen BF et al 1999 The effect of tetrandrine
and extracts of Centella asiatica on acute radiation dermatitis
in rats. Biological and Pharmaceutical Bulletin
22(7):703–706
D’Amelio F 1987 Gotu Kola. Cosmetics and Toiletries
102(6):49–50
Darnis F, Orcel L, De Saint-Maur PP, Mamou P 1979 Use of a
titrated extract of Centella asiatica in chronic hepatic disorders.
La Semaine Des Hopitaux 55(37–38):1749–1750
Dash B 1991 Materia medica of Ayurveda. B. Jain Publishers, New
Delhi, p 102
Dash B, Junius M 1983 A handbook of Ayurveda. Concept
Publishing, New Delhi, p 103
Downie S, Watson MF, Spalik K, Katz-Downie DS 2000 Molecular
systematics of Old World Apioideae (Apiaceae): relationships
among some members of tribe Peucedaneae sensu lato, the
placement of several island-endemic species, and resolution
within the apioid superclade. Canadian Journal of Botany
78:506–528
Eun HC, Lee AY 1985 Contact dermatitis due to madecassol.
Contact Dermatitis 13(5):310–313
Frawley D, Lad V 1986 The yoga of herbs: an Ayurvedic guide to
herbal medicine. Lotus Press, Santa Fe, p 170–171
Guseva NG, Starovoitova MN, Mach ES 1998 Madecassol treatment
of systemic and localized scleroderma. Terapevticheskii Arkhiv
70(5):58–61
Heinerman J 1984 An herb for our time: the scientific rediscovery of
Gotu Kola. Unpublished manuscript p 85
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1192
Leung AY, Foster S 1996 Encyclopedia of common natural ingredients
used in food, drugs and cosmetics, 2nd edn. John Wiley,
New York, p 284–285
Lin YC, Yang TI, Chen JY, Yang CS 1972 Search for biologically
active substances in Taiwan medicinal plants. 1. Screening for
antitumor and antimicrobial substances. Zhonghua Minguo
Wei Sheng Wu Xue Za Zhi 5(1):76–81
Maquart FX, Chastang F, Simeon A et al 1999 Triterpenes from
Centella asiatica stimulate extracellular matrix accumulation in
rat experimental wounds. European Journal of Dermatology
9(4):289–296
Montecchio GP, Samaden A, Carbone S 1991 Centella asiatica
Triterpenic Fraction (CATTF) reduces the number of circulating
endothelial cells in subjects with post phlebitic syndrome.
Haematologica 76(3):256–259
Mook-Jung I, Shin JE, Yun SH 1999 Protective effects of asiaticoside
derivatives against beta-amyloid neurotoxicity. Journal of
Neuroscience Research 58(3):417–425
Newall C, Anderson L, Phillipson JD 1996 Herbal medicines: a guide
for professionals. The Pharmaceutical Press, London,
p 170–172
Oliver-Bever B 1986 Medicinal plants in tropical West Africa.
Cambridge University Press, Cambridge, p 67
Ramaswamy AS, Pariyaswamy SM, Basu N 1970. Pharmacological
studies on Centella asiatica Linn. Journal of Research in Indian
Medicine 4:160–175
Shukla A, Rasik AM, Jain GK et al 1999a In vitro and in vivo wound
healing activity of asiaticoside isolated from Centella asiatica.
Journal of Ethnopharmacology 65(1):1–11.
Shukla A, Rasik AM, Dhawan BN 1999b Asiaticoside-induced elevation
of anti-oxidant levels in healing wounds. Phytotherapy
Research 13(1):50–54
Spencer TS 1985 Pseudofolliculitis barbae or razor bumps and
shaving. Cosmetics and Toiletries 100:47–49
Srikanthamurthy KR 1994 Va¯gbhat.
a’s As.t.
a¯ñga Hr. dayam, vol 1.
Krishnadas Academy, Varanasi, p 90
Srikanthamurthy KR 1995 Va¯gbhat.
a’s As.t.
a¯ñga Hr. dayam, vol 3.
Krishnadas Academy, Varanasi, p 438
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 274
Suguna L, Sivakumar P, Chandrakasan G 1996 Effects of Centella
asiatica extract on dermal wound healing in rats. Indian
Journal of Experimental Biology 34(12):1208–1211
Man.d.
u¯kaparn.
ı¯, ‘frog-leaved’ 243
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1994 Indian
medicinal plants: a compendium of 500 species, vol 2. Orient
Longman, Hyderabad, p 52, 54–55
Williamson EM (ed) 2002 Major herbs of Ayurveda. Churchill
Livingstone, London, p 103
Yoganarasimhan SN 2000 Medicinal plants of India, vol 2: Tamil
Nadu. Self-published, Bangalore, p 122
244 PART 2: A¯ yurvedic materia medica
Botany: Mañjis.t.
ha¯ is a perennial herbaceous
climber, branches and stems quadangular, the mature
portions covered in a whitish bark that is rather rough
and grooved, the roots long and cylindrical, covered in
a reddish bark, medulla deep red in colour. The leaves
are variable, margins entire, 3–9 cm long by 1–4 cm
wide, arranged in whorls of three to eight (usually
four), the petioles of one pair often longer than the
other, cordate-ovate to ovate-lanceolate, with five to
seven veins that arise from the base. The small white or
greenish flowers are borne in terminal panicles or
cymes, giving rise to a purplish-black globose fruit containing
two small seeds. Mañjis.t.
ha¯ is found in hilly
areas, up to 3750 m in elevation, in tropical Africa and
Southeast Asia, north and eastwards into Tibet and
China (Kirtikar & Basu 1935, Warrier et al 1996).
Part used: Root, stem.
Dravygun. a:
Rasa: madhura, tikta, ka´sa¯ya
Vipa¯ka: kat.u
Vı¯rya: us.n.
a
Karma: dı ¯panapa¯cana, purı ¯s.asangrahan. ı ¯ya,
jvaraghna, kr . mighna, mu¯travirecana, a´smaribhedana,
raktaprasa¯dana, ´son. itastha¯pana, ´sothahara, kus.t.
aghna,
vis.aghna, sandha¯nı ¯ya, vedana¯stha¯pana, caks.us.ya,
balya, rasa¯yana, kaphapittahara (Dash 1991,
Frawley & Lad 1986, Srikanthamurthy 2001,
Warrier et al 1996).
Constituents: Mañjis.t.
ha¯ contains a variety of
quinones including the anthraquinones cordifoliol
and cordifodiol, the quinoidal dimers naphthohydroquinone
anhydride, furomollugin, mollugin, and rubilactone,
as well as naphthoic acid esters. Mañjis.t.
ha¯
has also been shown to contain the iridoid glycosides
6-methoxygeniposidic acid, manjishtin, garancin and
alazarin. Triterpenoids include oleananes rubiprasin
A–C and arboranes rubiarbonol A–F. Researchers
have also isolated bicyclic hexapeptides RA-VII and
RA-X to RA-XVI, as well as -sitosterol and daucosterol
(Abdullah et al 2003, Hassanean et al 2000,
Ho et al 1996, Hua et al 1992, Itokawa et al 1993,
Kapoor 1990, Morita et al 1992, Qiao et al 1990,
Takeya et al 1993, Wang et al 1992, Williamson
2002).
Medical research:
In vitro: antioxidant (Pandey et al 1994, Tripathi
et al 1997, 1998), anti-HBsAg (Ho et al 1996),
antispasmodic (Gilani et al 1994), antithrombotic
(Tripathi et al 1993).
In vivo: GABA-nergic, serotinergic, antiseizure
(Kasture et al 2000).
Toxicity: The oral LD50 is stated to be greater than
175 g/kg in mice (Bensky & Gamble 1993).
Indications: Dyspepsia, colic, diarrhoea, dysentery,
intestinal parasites, haemorrhoids, jaundice, hepatitis,
splenitis, intermittent fever, pharyngitis, cough,
oedema, skin diseases, wounds, ulcers, broken bones,
amenorrhea, dysmenorrhoea, metrorrhagia, haemorrhage,
urinary tenesmus, inflammatory joint disease,
neuralgia, pain, diabetes, cancer.
Contraindications: va¯takopa.
Medicinal uses: Mañjis.t.
ha¯ is revered as a potent
alterative or raktaprasa¯dana in A¯ yurvedic medicine,
acting on the liver and kidneys to mobilise toxins from
the tissues and blood for elimination. It is particularly
useful to break up congestion and stagnation in tissues
by enhancing circulation (hence it has an us.n.
a
vı¯rya), and thus finds utility in a range of conditions,
from tumours to chronic infection. The traditional
Mañjis.t.
ha¯
BOTANICAL NAME: Rubia cordifolia, Rubiaceae
OTHER NAMES: Manjit (H); Manjitti, Shevvelli (T); Indian Madder (E);
Qian cao gen (C)
Mañjis.t.
ha¯ 245
indication to use Mañjis.t.
ha¯ in blood disorders can be
inferred from its intensely red pigment, which resembles
the colour of blood. Thus Mañjis.t.
ha¯ can be used
whenever there is inflammation or bleeding, from
inflammatory skin conditions, such as acne, to dysfunctional
uterine bleeding. Manijishta is still used in
countries like India to dye cloth, and when applied topically
or taken internally, this dye can temporarily
colour the skin and urine red. Mañjis.t.
ha¯ is valued in
both urinary lithiasis and cholelithiasis, and stated to
be effective in both calcium phosphate and oxalate
stones of the bladder (Nadkarni 1954). Mañjis.t.
ha¯ is
similarly indicated in haematuria, with herbs such as
Goks.ura and Agnimañtha. Taken internally with
herbs such as Yastimadhu, Gud.u¯cı¯, Kat.uki and
Candana, Mañjis.t.
ha¯ may be effective in peptic ulcer
(amlapitta). In the treatment of consumptive conditions
with epistaxis Mañjis.t.
ha¯ may be effective when
used in combination with herbs such as Arjuna,
malakı¯, Va¯saka and Pus.karamu¯la. In the treatment
of rheumatoid arthritis, lupus and gout
Mañjis.t.
ha¯ is often applied topically as a medicated oil,
often in the form of preparation called Pin.d.
a taila,
composed of Mañjis.t.
ha¯, Sarjasa resin, Sa¯riva¯ and
beeswax, decocted in water and sesame oil. The
Cakradatta recommends a formula similarly useful
in the internal treatment of inflammatory joint disease,
comprising equal parts Mañjis.t.
ha¯, A¯malakı¯,
Harı¯takı¯, Bibhı¯taka, Nimba, Vaca¯, Kat.uka,
Gud.u¯cı¯ and Da¯ruharidra¯ in decoction or as a cu¯rn.
a
(Sharma 2002). In the treatment of vomiting of blood
or bleeding from the nose the Cakradatta recommends
a medicated ghr. ta prepared with Mañjis.t.
ha¯.
As its name might suggest, this herb is also indicated
in mañjis.t.
ha¯ prameha, a polyuria in which the urine
is bright red – for this purpose the Cakradatta
recommends a combination of Mañjis.t.
ha¯ and
Raktacandana (Sharma 2002). In the treatment of
wounds Mañjis.t.
ha¯ can be applied singly as a powder
or with equal parts herbs, such as Triphala,
Haridra¯, Nimba and Yas.t.imadhu. In the same fashion,
Mañjis.t.
ha¯ is also applied to ulcers and tumours
in combination with a variety of medicaments. To prevent
miscarriage the Cakradatta recommends a milk
decoction of Mañjis.t.
ha¯, ´Sata¯varı¯, Tila and As.mantaka,
taken for the first 7 months of pregnancy in susceptible
women (Sharma 2002). Prepared as a
medicated ghr. ta with Triphala, Mañjis.t.
ha¯ can be
used in conjunctivitis and glaucoma. In the patients
having undergone chemotherapy for lung and
oesophageal cancer presenting with haemoptysis,
Mañjis.t.
ha¯ can be combined with A´svagandha¯ and
Yas.t.
imadhu to promote healing. Chinese herbal
medicine corroborates many of the traditional
yurvedic uses for Mañjis.t.
ha¯, using it in the treatment
of bleeding disorders and in blood stasis, and in
pain from trauma or joint pain (Bensky & Gamble
1993).
Dosage:
Cu¯rn.
a: 3–5 g b.i.d.–t.i.d.
Kva¯tha: 1:4, 30–120 mL b.i.d.–t.i.d.
Tincture: dried root, 1:3, 50% alcohol, 1–5 mL
b.i.d.–t.i.d.
Taila: ad lib. in abhyan . ga etc. for inflammatory
joint disorders.
REFERENCES
Abdullah ST, Ali A, Hamid H et al 2003 Two new anthraquinones
from the roots of Rubia cordifolia Linn. Die Pharmazie
58(3):216–217
Bensky D, Gamble A 1993 Chinese herbal medicine materia medica,
revised edn. Eastland Press, Seattle, p 258
Dash B 1991 Materia medica of Ayurveda. B. Jain Publishers, New
Delhi, p 78
Frawley D, Lad V 1986 The yoga of herbs: an Ayurvedic guide to
herbal medicine. Lotus Press, Santa Fe, p 178
Gilani AH, Janbaz KH, Zaman M et al 1994 Possible presence of calcium
channel blocker(s) in Rubia cordifolia: an indigenous
medicinal plant. Journal of the Pakistan Medical Association
44(4):82–85
Hassanean HA, Ibraheim ZZ, Takeya K, Itorawa H 2000 Further
quinoidal derivatives from Rubia cordifolia L. Die Pharmazie
55(4):317–319
Ho LK, Don MJ, Chen HC et al 1996 Inhibition of hepatitis B surface
antigen secretion on human hepatoma cells. Components from
Rubia cordifolia. Journal of Natural Products 59(3):330–333
Hua HM, Wang SX, Wu LJ et al 1992 Studies on naphthoic acid
esters from the roots of Rubia cordifolia L. Yao Xue Xue Bao
27(4):279–282
Itokawa H, Ibraheim ZZ, Qiao YF, Takeya K 1993 Anthraquinones,
naphthohydroquinones and naphthohydroquinone dimers
from Rubia cordifolia and their cytotoxic activity. Chemical and
Pharmaceutical Bulletin (Tokyo) 41(10):1869–1872
Kapoor LD 1990 CRC handbook of Ayurvedic medicinal plants.
CRC Press, Boca Raton, p 292
Kasture VS, Deshmukh VK, Chopde CT 2000 Anticonvulsant and
behavioral actions of triterpene isolated from Rubia cordifolia
Linn. Indian Journal of Experimental Biology 38(7):675–680
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1303–1304
Morita H, Yamamiya T, Takeya K, Itokawa H 1992 New antitumor
bicyclic hexapeptides, RA-XI, -XII, -XIII and -XIV from Rubia
cordifolia. Chemical and Pharmaceutical Bulletin (Tokyo)
40(5):1352–1354
246 PART 2: A¯ yurvedic materia medica
Nadkarni KM 1954 The Indian materia medica, with Ayurvedic,
Unani and home remedies, revised and enlarged by A.K.
Nadkarni. Popular Prakashan PVP, Bombay, p 1076
Pandey S, Sharma M, Chaturvedi P, Tripathi YB 1994 Protective
effect of Rubia cordifolia on lipid peroxide formation in isolated
rat liver homogenate. Indian Journal of Experimental Biology
32(3):180–183
Qiao YF, Wang SX, Wu LJ 1990 Studies on antibacterial constituents
from the roots of Rubia cordifolia L. Yao Xue Xue Bao
25(11):834–839
Sharma PV 2002 Cakradatta: Sanskrit text with English translation.
Chaukhamba, Varanasi, p 236, 326, 585
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 190
Takeya K, Yamamiya T, Morita H, Itokawa H 1993 Two antitumor
bicyclic hexapeptides from Rubia cordifolia. Phytochemistry
33(3):613–615
Tripathi YB, Sharma M 1998 Comparison of the anti-oxidant
action of the alcoholic extract of Rubia cordifolia with
rubiadin. Indian Journal of Biochemistry and Biophysics
35(5):313–316
Tripathi YB, Pandey S, Shukla SD 1993 Antiplatelet activating factor
property of Rubia cordifolia Linn. Indian Journal of
Experimental Biology 31(6):533–535
Tripathi YB, Sharma M, Manickam M 1997 Rubiadin, a new antioxidant
from Rubia cordifolia. Indian Journal of Biochemistry
and Biophysics 34(3):302–306
Wang SX, Hua HM, Wu LJ 1992 Studies on anthraquinones from
the roots of rubia cordifolia. Yao Xue Xue Bao
27(10):743–747
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1996 Indian medicinal
plants: a compendium of 500 species, vol 5. Orient
Longman, Hyderabad, p 17
Williamson EM (ed) 2002 Major herbs of Ayurveda. Churchill
Livingstone, London, p 258
Yoganarasimhan SN 2000 Medicinal plants of India, vol 2: Tamil
Nadu. Self-published, Bangalore
Mustaka 247
Botany: Mustaka is a perennial, herbaceous sedge
attaining a height of up to 75 cm, with elongated,
slender stolons interspersed by aromatic tubers, 1–3
cm in length, the cortex black, the medulla reddishwhite.
The leaves are shorter than the stem, glabrous,
linear, dark green, finely acuminate, flat, with a single
vein. The flowers are borne in spikes arranged as simple
or compound umbels, each spike in turn composed
of several spikelets containing small flowers with
a reddish-brown husk. The fruit is an obovoid, greyishbrown,
three-angled nut that is black when mature.
Mustaka is stated to be native to India, but is now
found all over the world and is considered by many to
be an invasive weed of wet, marshy places (Kirtikar &
Basu 1935, Warrier et al 1994).
Part used: Tuber.
Dravygun. a:
Rasa: tikta, ka´sa¯ya
Vipa¯ka: kat.u
Vı¯rya: ´sita
Karma: dı ¯panapa¯cana, purı ¯s.asangrahan. ı ¯ya,
jvaraghna, chedana, kr . mighna, mu¯travirecana,
a´smaribhedana, kus.t.
aghna, ´son. itastha¯pana,
sandha¯nı ¯ya, a¯rtavajanana, stanyajanana,
vedana¯stha¯pana, medhya, kaphapittahara
(Srikanthamurthy 2001, Warrier et al 1994).
Constituents: Mustaka contains an essential oil that
provides for the characteristic odour and taste of the
herb, mostly consisting of sesquiterpene hydrocarbons,
epoxides, ketones, monoterpenes and aliphatic
alcohols. Sesquiterpenes include -selinene, isocurcumenol,
nootkatone, aristolone, isorotundene,
cypera-2,4(15)-diene, and norrotundene, as well as
the sesquiterpene alkaloid rotundines A–C. Other
constituents include the ketone cyperadione, and the
monoterpenes cineole, camphene and limonene.
Mustaka has also been shown to contain miscellaneous
triterpenes including oleanolic acid and -sitosterol,
as well as flavonoids, sugars and minerals
(Ha et al 2002, Jeong et al 2000, Kapoor 1990, Sonwa
& Konig 2001, Williamson 2002).
Medical research:
In vitro: antitoxic (Daswani et al 2001), antimalarial
(Weenen et al 1990), GABA nergic
(Ha et al 2002), antioxidant (Seo et al 2001).
In vivo: antitoxic (Daswani et al 2001).
Human trials: obese patients given an extract of
Mustaka over a 90-day period were found to have
experienced a reduction in weight, as well as a similar
reduction in serum triglycerides and cholesterol
(Williamson 2002).
Toxicity: The LD50 of an ethanolic extract was determined
to be 1500 mg/kg (Williamson 2002).
Indications: Nausea and vomiting, dyspepsia, colic,
flatulence, diarrhoea, dysentery, intestinal parasites,
fever, malaria, cough, bronchitis, renal and vesical
calculi, urinary tenesmus, skin diseases, wounds,
amenorrhoea, dysmenorrhoea, deficient lactation.
Contraindications: va¯takopa, constipation.
Medicinal uses: Mustaka is an important medicinal
plant in A¯ yurvedic medicine, a bitter tasting aromatic
herb that acts to enkindle agni, dispel a¯ma, and
relieve intestinal spasm. Overall, Mustaka helps to
normalise excessive secretion, and in this way tends to
have a constipating activity that makes it particularly
effective in diarrhoea. While it is used in formulation
to treat dysentery, it is particularly useful after initial
treatment, used over the medium term to restore
digestive health and combat any lingering infection. It
Mustaka
BOTANICAL NAME: Cyperus rotundus, Cyperaceae
OTHER NAMES: Motha (H); Korai (T); Nut Grass (E); Xiang fu (C)
248 PART 2: A¯ yurvedic materia medica
is also used in non-infective digestive disorders, however,
marked by intestinal spasm, bloating, and a tendency
to loose motions. The Cakradatta recommends
a variety of formulations containing Mustaka in the
treatment of diarrhoea, depending on the severity and
associated symptoms. For severe diarrhoea Mustaka
is combined with herbs such as Kut.aja, Bilva,
Da¯d.ima, and Dha¯taki, along with antimicrobial
botanicals such as Kat.uka, Gud.u¯cı¯ and
Da¯ruharidra¯, and antispasmodic herbs such as Vaca¯
and Ela¯. For diarrhoea with symptoms of burning
sensation and thirst, Mustaka is combined with cooling
botanicals such as Candana, Dha¯nyaka and
Bala¯ka. In diarrhoea with symptoms of a¯ma, in
which the bowel movements have a foul odour and are
accompanied by severe colic, Mustaka is combined
with botanicals such as Harı¯takı¯, ´Su¯n.t.
hı¯, Hin.gu and
Pippalı¯. In the treatment of intestinal parasites the
Cakradatta recommends Musta¯di kva¯tha, which
consists of a decoction of Mustaka, Mu¯s.a¯karn.
i,
Triphala, ´Sigru and Devada¯ru, with the pastes of
Pippalı¯ and Vid.
an.ga (Sharma 2002). In the treatment
of cough, bronchitis and asthma Mustaka can
be combined with botanicals such as Va¯saka,
Haridra¯, Bibhı¯taka, Pippalı¯, Kan.
t.
aka¯ri, and
Pus.karamu¯la. In the treatment of inflammatory
joint disease (a¯mava¯ta) Mustaka is used as an
adjunct to herbs such as Guggulu, Gud.u¯cı¯, Citraka,
´Su¯n.t.
hı¯ and Triphala, to relieve pain and enkindle
agni. In the treatment of diabetes Mustaka is used in
conjunction with herbs such as Triphala, Devada¯ru,
Gud.u¯cı¯, Guggulu, Haridra¯ and ´Sila¯jatu. The antispasmodic
properties of the root also make it helpful in
gynaecological disorders such as premenstrual tension,
dysmenorrhoea, endometritis, all more or less
attended by loose motions or diarrhoea. Mustaka is
also taken internally and applied topically as a fresh
plant poultice as a galactagogue.
Dosage:
Cu¯rn.
a: 3–5 g b.i.d.–t.i.d.
Kva¯tha: 1:4, 30–90 mL b.i.d.–t.i.d.
Tincture: dried root, 1:3, 50% alcohol, 1–5 mL
b.i.d.–t.i.d.
REFERENCES
Daswani PG, Birdi TJ, Antia NH 2001 Study of the action of
Cyperus rotundus root decoction on the adherence and enterotoxin
production of diarrhoeagenic Escherichia coli. Indian
Journal of Pharmacology 33:116–117
Ha JH, Lee KY, Choi HC et al 2002 Modulation of radioligand binding
to the GABA(A)-benzodiazepine receptor complex by a new
component from Cyperus rotundus. Biological and
Pharmaceutical Bulletin 25(1):128–130
Jeong SJ, Miyamoto T, Inagaki M et al 2000 Rotundines A–C, three
novel sesquiterpene alkaloids from Cyperus rotundus. Journal
of Natural Products 63(5):673–675
Kapoor LD 1990 CRC Handbook of Ayurvedic medicinal plants.
CRC Press, Boca Raton, p 292
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 2638–2639
Seo WG, Pae HO, Oh GS et al 2001 Inhibitory effects of methanol
extract of Cyperus rotundus rhizomes on nitric oxide and
superoxide productions by murine macrophage cell line,
RAW 264.7 cells. Journal of Ethnopharmacology
76(1):59–64
Sharma PV 2002 Cakradatta: Sanskrit text with English translation.
Chaukhamba, Varanasi, p 110
Sonwa MM, Konig WA 2001 Chemical study of the essential oil of
Cyperus rotundus. Phytochemistry 58(5):799–810
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 220
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1994 Indian
medicinal plants: a compendium of 500 species, vol 2. Orient
Longman, Hyderabad, p 296–299
Weenen H, Nkunya MH, Bray DH et al 1990 Antimalarial activity
of Tanzanian medicinal plants. Planta Medica 56(4):368–370
Williamson EM (ed) 2002 Major herbs of Ayurveda. Churchill
Livingstone, London, p 122–124
Na¯gake´sara, ‘serpent stamens’ 249
Na¯gake´sara, ‘serpent stamens’
BOTANICAL NAMES: Mesua ferrea, M. nagassarium, Clusiaceae
OTHER NAMES: Nagapus.pa, ‘serpent flowers’ (S); Nagkesar (H); Nagappu,
Nanku (T); Ironwood (E)
Botany: Na¯gake´sara is a medium to large sized tree
that can attain a height of between 18 and 30 m, with
reddish-brown to greyish coloured bark that peels off
in thin flakes, the wood extremely hard. The leaves are
simple, lanceolate, acute, leathery, covered in a waxy
bloom below, red when young, oppositely arranged,
7–13 cm long by 2–4 cm wide. The flowers are white
with a floral fragrance, up to 7.5 cm in diameter, with
numerous golden-colored stamens shorter than the
length of the petals, the style twice as long as the
stamens, borne singly or in pairs, axillary or terminal.
The fruits are ovoid with a conical point, 2.5–5 cm
long, with a woody pericarp that contains one to
four seeds. Na¯gake´sara is found throughout
Southeast Asia in tropical evergreen forests up to
1500 m in elevation (Kirtikar & Basu 1935, Warrier
et al 1995).
Part used: Flowers.
Dravygun. a:
Rasa: ka´sa¯ya, tikta
Vipa¯ka: kat.u
Vı¯rya: us.n.
a, ru¯ks.
a
Karma: dı ¯panapa¯cana, purı ¯s.asangrahan. ı ¯ya,
jvaraghna, chedana, mu¯travirecana, mu¯travi´sodhana,
´son. itastha¯pana, hr . daya, vis.aghna, vedana¯stha¯pana,
vajı ¯karan. a, tridos.aghna (Srikanthamurthy 2001,
Warrier et al 1995).
Constituents: The flowers of Mesua ferrea contain a
yellow-coloured highly fragrant essential oil, the
stamens specifically containing mesuanic acid,
-amyrin, -amyrin, -sitosterol, and the biflavonoids
mesuaferrone A and B. Researchers have also isolated
a group of xanthones from M. ferrea, including
euxanthone, dehydrocycloguanadin, jacareubin, and
mesuaxanthones A and B. The seed contains the
coumarin mesaugin, the lactones mesuol, mesuone,
and mammeisin, as well as a fixed oil comprising oleic,
stearic, palmatic and linoleic acids (Gopalkrishnan et al
1980, Kapoor 1990, Yoganarasimhan 2000).
Medical research:
In vitro: antibacterial (Kapoor 1990).
In vivo: CNS depressant (Gopalkrishnan et al
1980), anti-inflammatory (Gopalkrishnan et al
1980), anti-asthmatic (Kapoor 1990).
Toxicity: There have been some reports of aflatoxins
in the seed oil, probably from poor storage conditions
(Roy & Chourasia 1989).
Indications: Vomiting, halitosis, ulcer, dysentery,
bleeding haemorrhoids, fever, cough, pharyngitis,
asthma, haemoptysis, skin diseases, buring sensations,
cystitis, cardiac debility, headache, leucorrhoea,
impotency.
Contraindications: No data found.
Medicinal uses: Na¯gake´sara is valued as a pleasantly
fragrant herb that can help to improve the odour
of formulations, with an astringent, pa¯cana property
that acts to clear away congestion and a¯ma. Although
classified as mildly warming Na¯gake´sara is an important
herb to use for pittakopa conditions such as
dysentery and burning sensations. Va¯ttika conditions
are also stated to be pacified by it (Warrier et al 1995),
probably by virtue of its dı¯panapa¯cana property
as well as due to the pleasing, uplifting fragrance of
the essential oil. The As.t.
a¯ñga Hr.
daya includes
Na¯gake´sara in a list of medicinal plants that are used
to counter the effects of poison, treat skin rashes and
itching, and reduce all three dos.as (Srikanthamurthy
1994). In the treatment of haemorrhoids Na¯gake´sara
is used in a variety of formulations depending on the
250 PART 2: A¯ yurvedic materia medica
causative factor. For haemorrhoids associated with
kapha, four parts Na¯gake´sara can be mixed with
seven parts ´Su¯n.t.
hı¯, six parts Pippalı¯, five parts
Marica, three parts Patra leaf, two parts Tvak bark
and one part Ela¯ (Sharma 2002). For bleeding haemorrhoids
Na¯gake´sara can be prepared as a medicated
ghr. ta mixed with equal parts Kut.aja, Nı¯lotpala,
Lodhra, and Dha¯taki, taken in doses of 3–12 g
(Sharma 2002). For a more simplified approach, the
cu¯rn.
a of Na¯gake´sara is mixed with butter and sugar
and taken internally in the treatment of haemorrhoids
and dysentery (Sharma 2002). Nadkarni states
that this preparation is similarly useful in thirst,
gastric irritation, excessive perspiration, and cough
(1954). Prepared as a medicated ghr. ta Na¯gake´sara
can also be applied topically in haemorrhoids, and can
be similarly applied in the treatment of burning and
tingling sensations of the feet (Nadkarni 1954,
Sharma 2002). In the treatment of skin diseases and
obesity a cu¯rn.
a of Na¯gake´sara can be mixed with
equal parts ´Siris.a, La¯majjaka, and Lodhra, applied
in udavartana abhyan.ga (Sharma 2002).
Na¯gake´sara is stated to be useful in symptoms of
gonorrhoea and renal diseases, and can be used as a
substitute for Cavya in the treatment of diseases of
the urinary tract (Kapoor 1990, Nadkarni 1954).
Dosage:
Cu¯rn.
a: 3–5 g b.i.d.–t.i.d.
Hima: 30–90 mL bi.d.–t.i.d.
REFERENCES
Gopalkrishnan C, Shankaranarayanan D, Nazimudeen SK et al
1980 Anti-inflammatory and CNS depressant activities of xanthones
from Calophyllum inophyllum and Mesua ferrea. Indian
Journal of Pharmacology 12(3):181–191
Kapoor LD 1990 CRC Handbook of Ayurvedic medicinal plants.
CRC Press, Boca Raton, p 228–229
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 274–5
Nadkarni KM 1954 The Indian materia medica, with Ayurvedic,
Unani and home remedies, revised and enlarged by A.K.
Nadkarni. Popular Prakashan PVP, Bombay, p 794–795
Roy AK, Chourasia HK 1989 Aflatoxin problems in some medicinal
plants under storage. International Journal of Crude Drug
Research 27(3):156–160
Sharma PV 2002 Cakradatta: Sanskrit text with English translation.
Chaukhamba, Varanasi, p 83, 89, 90, 204, 338
Srikanthamurthy KR 1994 Va¯gbhat.
a’s As.t.a¯ñga Hr. dayam, vol 1.
Krishnadas Academy, Varanasi, p 202, 207
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 217
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1995 Indian
medicinal plants: a compendium of 500 species, vol 4. Orient
Longman, Hyderabad, p 27–30
Yoganarasimhan SN 2000 Medicinal plants of India, vol 2: Tamil
Nadu. Self-published, Bangalore, p 353
Nimba, ‘bestower of health’ 251
Botany: Nimba is a medium to large evergreen tree,
attaining a height of between 15 and 20 m, with a
straight trunk, widely spreading branches, and greyish
tubercled bark. The leaves are alternate and imparipinately
compound, with 7–17 leaflets arranged in
pairs, often with a terminal leaflet, ovate to lanceolate,
sickle-shaped with an uneven base and serrate margins,
6–8 cm long, 1–3 cm wide. The flowers are
cream to yellow in colour, borne in axillary panicles,
giving rise to a single seeded ellipsoid drupe that is
greenish-yellow when ripe. Nimba is widely cultivated
in tropical and subtropical regions all over the
world, and is thought to be native to the subcontinent
(Kirtikar & Basu 1935).
Part used: Bark, leaves (Nimbapatra), seeds
(Nimbaphala).
Dravygun. a:
Rasa: ka´sa¯ya, tikta
Vipa¯ka: kat.u
Vı¯rya: ´sita
Karma: dı ¯panapa¯cana, vamana, purı ¯s.asangrahan. ı ¯ya,
kr . mighna, jvaraghna, chedana, da¯hapra´samana,
raktaprasa¯dana, kus.t.
haghna, mu¯travirecana,
mu¯travi´sodhana, sandha¯nı ¯ya, vis.aghna,
pittakaphahara (Srikanthamurthy 2001, Warrier
et al 1994).
Constituents: Nimba is a fairly well researched medicinal
plant, and as a result a number of constituents have
been isolated from it. Among these are bitter-tasting terpenes
called limonoids, including azadirachtin, nimbanal,
nimbidiol, margocin, margocinin and related
compounds, as well as a variety of other terpenoids
including isoazadirolide, nimbocinolide, gedunin, margosinone
and nimbonone. More recently, researchers
have isolated a series of tetranortriterpenoids including
azadirachtol, 1, 2-epoxy-17−hydroxyazadiradione,
1, 2-epoxynimolicinol, and 7-deacetylnimolicinol.
Other constituents include the flavonoids kaempferol,
quercetin, quercitrin, rutin, and myricetin, as well as -
sitosterol, a tannin, a gum, and a series of polysaccharides
named CSP-II and -III, CSSP-I, -II, and -III, etc.
(Duke 2003, Hallur et al 2002, Kapoor 1990, Luo et al
2000, Malathi et al 2002, Williamson 2002).
Medical research:
In vitro: negatively ionotropic/chronotropic
(Kholsa et al 2002), hypotensive (Chattopadhyay
1997), antiviral (Badam et al 1999; Parida et al
2002), antifungal (Fabry et al 1996), antibacterial
(Almas 1999, Alzoreky & Nakahara 2003).
In vivo: hepatoprotective (Arivazhagan et al
2000; Bhanwra et al 2000), anti-ulcerogenic
(Bandyopadhyay et al 2002), hypoglycaemic
(Kholsa et al 2000), hypotensive (Koley & Lal
1994), immunostimulant (Mukherjee et al 1999,
Njiro & Kofi-Tsekpo 1999, Upadhyay et al 1992),
anti-inflammatory (Chattopadhyay et al 1998),
antitumour (Kumar et al 2002; Tepsuwan et al
2002), anxiolytic (Jaiswal et al 1994), antifertility
(Kasturi et al 2002, Mukherjee et al 1999,
Parshad et al 1994), antiviral (Parida et al 2002).
Human trials: a lyophilised powder of Nimba
extract administered over 10 days, 30–60 mg twice
daily, caused a significant decrease in gastric acid
secretion and pepsin activity, and when taken for
between 6 and 10 weeks almost completely healed
lesions in patients suffering from duodenal, gastric
and oesophageal ulcers (Bandyopadhyay et al
2004). An extract of Nimba was found to lower
total serum cholesterol and LDL-cholesterol levels
in non-malarial patients, while increasing triacylglycerol
and HDL-cholesterol in malarial patients
(Njoku et al 2001). A Nimba mouth rinse was
found to be active against Streptococcus mutans
Nimba, ‘bestower of health’
BOTANICAL NAMES: Azadirachta indica, Melia azadirachta, Meliaceae
OTHER NAMES: Nim, Nimb (H); Vempu, Veppu (T); Neem, Margosa (E)
252 PART 2: A¯ yurvedic materia medica
and reversed incipient carious lesions (Vanka et al
2001); a dental gel containing Nimba leaf extract
(25 mg/g) was found to significantly reduce the
plaque index and bacterial count compared to
chlorhexidine gluconate (0.2% w/v) mouthwash
(Pai et al 2004). A paste prepared from Nimba and
Haridra¯ was found to promote a 97% cure rate in
scabies within 3 to 15 days of treatment, with
no toxic or adverse reactions (Charles & Charles
1992); a 2% Nimba oil mixed in coconut oil
applied to the exposed body parts of human volunteers
provided complete protection from mosquito
bites over a 12-hour period (Sharma et al 1993).
Toxicity: A cumulative oral dose of the crude bark
extract of Nimba, of 1–9 g/kg in mice over a 15-day
period, was well tolerated and below the LD50
(Bandyopadhyay et al 2002). The seed oil of Nimba
was determined to have a 24-hour oral LD50 of 14
ml/kg in rats and 24 ml/kg in rabbits. The lungs and
central nervous system appeared to be the target
organs of toxicity. In comparison, a mustard seed oil
was determined to have an oral LD50 of 80 ml/kg
(Gandhi et al 1988). Chewing sticks made from
Azadirachta indica were observed to be susceptible
to post-harvest spoilage and are not advisable for oral
hygiene measures if not fresh (Etebu et al 2003).
Indications: Dyspepsia, ulcers, intestinal parasites,
haemorrhoids, liver diseases, fever, malarial fever,
cough, bronchitis, asthma, tuberculosis, skin diseases,
inflammatory joint disease, cystitis, amenorrhoea,
diabetes, tumours, conjunctivitis and ophthalmic disorders
generally.
Contraindications: va¯takopa.
Medicinal uses: The name Nimba is an ancient
name, derived from the Sanskrit phrase ‘nimbati
sva¯sthyamdadati’, meaning ‘bestower of good
health’. Nimba is a sacred tree in India, associated
with Laks.mı¯, the goddess of abundance and good fortune,
and Surya, the sun. It has a bitter taste and
a cooling energy, acting to remove congestion and
reduce inflammation, and is thus reserved for afflictions
of pitta and kapha. Although one study
indicates an anxiolytic effect, the Bha¯vapraka¯´sa
states specifically that it is ‘bad for the heart’, and
‘unpleasant for the mind’ (Srikanthamurthy 2001).
Nimba is an important herb in fever, used in simple
formulations such as a soup prepared with Pat.
ola
(Sharma 2002). It is also used in more complex formulations
such as Nimba¯di kva¯tha, used in the treatment
of masu¯rika¯, or chicken pox, composed of
equal parts Nimba, Harı¯takı¯, Kat.uka, Va¯saka,
U´sı¯ra, A¯ malakı¯, Candana, Parpat.a, Dura¯labha¯,
Pat.
ola, and Raktacandana (Sharma 2002). In the
treatment of jaundice the Cakradatta recommends a
buffalo milk decoction of Nimba, Haridra¯, Pippalı¯,
Bala¯ and Yas.t.
imadhu (Sharma 2002). In the treatment
of acid reflux and vomiting associated with gastritis,
as well as colic and fever, the Cakradatta
recommends a decoction of Nimba, Gud.u¯cı¯,
Triphala and Pat.
ola, taken cool with honey (Sharma
2002). In the treatment of unma¯da (‘psychosis’)
Nimba leaves are reduced to a powder with Vaca¯,
Hin.gu, Sars.
apa seed and the discarded skin of a
snake, and burned as an incense (Sharma 2002). In
the treatment of gout and eczema Nimba is mixed
with equal parts Triphala, Mañjis.t.
ha¯, Vaca¯,
Kat.uka, Gud.u¯cı¯ and Da¯ruharidra¯, taken as a cu¯rn.
a
or kva¯tha (Sharma 2002). In combination with
Punarnava¯, Kat.uka, Gud.u¯cı¯, Devada¯ru, Harı¯takı¯,
Pat.
ola, and ´Su¯n.t.hı¯, Nimba is stated to be an effective
treatment for intestinal parasites associated with
anaemia and dyspnoea (Sharma 2002). Mixed with
Haridra¯, Nimba has been shown to be an effective
remedy in the treatment of scabies, and similar formulations
can be used in udavartana abhyan.ga in
the treatment of obesity and oedema. Nimba is also
used in premature ageing and greyness associated
with anger and physical strain, used as a simple medicated
taila in nasya therapy for a period of 1 month
(Sharma 2002). Nimba flowers are traditionally used
in Tamil cookery, stir-fried with pepper, mustard seed,
and Hin.gu in ghee, after which water, tamarind
paste, curry leaves and salt are added as the base of a
spicy, flavourable dı¯panapa¯cana soup. Nimba has
recently undergone much investigation for its insecticidal
properties against disease-carrying insects such
as mosquitoes and common agricultural pests such as
flies, beetles, worms, cockroaches and moths, but
appears to cause little harm to beneficial insects such
as wasps, butterflies, bees, spiders and earthworms
(Vietmeyer 1992). Organic farmers can thus take
advantage of Nimba’s insecticidal properties to good
advantage, and people can apply the diluted oil (2%) to
ward off mosquitos, without fear of harm. Some studNimba,
‘bestower of health’ 253
ies suggest that Nimba may act as a contraceptive, but
this application is still in the experimental stage.
Dosage:
Cu¯rn.
a: bark, leaf, 1–2 g b.i.d.–t.i.d.
Svarasa: leaf, 6–12 mL b.i.d.–t.i.d.
Hima: leaf, 30–90 mL b.i.d.–t.i.d.
Kva¯tha: bark, 30–60 mL b.i.d.–t.i.d.
Seed oil: topically only, 2–50% v/v in a carrier oil.
REFERENCES
Almas K 1999 The antimicrobial effects of extracts of Azadirachta
indica (Neem) and Salvadora persica (Arak) chewing sticks.
Indian Journal of Dental Research 10(1):23–26
Alzoreky NS, Nakahara K 2003 Antibacterial activity of extracts
from some edible plants commonly consumed in Asia.
International Journal of Food Microbiology 80(3):223–230
Arivazhagan S, Balasenthil S, Nagini S 2000 Garlic and Neem leaf
extracts enhance hepatic glutathione and glutathione dependent
enzymes during N-methyl-N’-nitro-N-nitrosoguanidine
(MNNG)-induced gastric carcinogenesis in rats. Phytotherapy
Research 14(4):291–293
Badam L, Joshi SP, Bedekar SS 1999 In vitro antiviral activity of
Neem (Azadirachta indica. A. Juss) leaf extract against group B
coxsackieviruses. Journal of Communicable Diseases
31(2):79–90
Bandyopadhyay U, Biswas K, Chatterjee R et al 2002 Gastroprotective
effect of Neem (Azadirachta indica) bark extract: possible
involvement of H()-K()-ATPase inhibition and scavenging of
hydroxyl radical. Life Sciences 71(24):2845–2865
Bandyopadhyay U, Biswas K, Sengupta A et al 2004 Clinical studies
on the effect of Neem (Azadirachta indica) bark extract on gastric
secretion and gastroduodenal ulcer. Life Sciences
75(24):2867–2878.
Bhanwra S, Singh J, Khosla P 2000 Effect of Azadirachta indica
(Neem) leaf aqueous extract on paracetamol-induced liver
damage in rats. Indian Journal of Physiology and
Pharmacology 44(1):64–68
Charles V, Charles SX 1992 The use and efficacy of Azadirachta indica
ADR (Neem) and Curcuma longa (‘Turmeric’) in scabies. A pilot
study. Tropical and Geographical Medicine 44(1–2):178–181
Chattopadhyay RR 1997 Effect of Azadirachta indica hydroalcoholic
leaf extract on the cardiovascular system. General
Pharmacology 28(3):449–451
Chattopadhyay RR 1998 Possible biochemical mode of anti-inflammatory
action of Azadirachta indica A. Juss. in rats. Indian
Journal of Experimental Biology 36(4):418–420
Duke JA (accessed 2003) Chemicals and their biological activities.
In: Azadirachta indica A. JUSS. (Meliaceae): Neem.
Agricultural Research Service (ARS), United States Department
of Agriculture. Available: http://www.ars-grin.gov/duke/
Etebu E, Tasie AA, Daniel-Kalio LA 2003 Post-harvest fungal quality
of selected chewing sticks. Oral Diseases 9(2):95–98
Fabry W, Okemo P, Ansorg R 1996 Fungistatic and fungicidal activity
of east African medicinal plants. Mycoses 39(1–2):67–70
Gandhi M, Lal R, Sankaranarayanan A et al 1988 Acute toxicity
study of the oil from Azadirachta indica seed (Neem oil).
Journal of Ethnopharmacology 23(1):39–51
Hallur G, Sivramakrishnan A, Bhat SV 2002 Three new tetranortriterpenoids
from Neem seed oil. Journal of Natural Products
65(8):1177–1179
Jaiswal AK, Bhattacharya SK, Acarya SB 1994 Anxiolytic activity
of Azadirachta indica leaf extract in rats. Indian Journal of
Experimental Biology 32(7):489–491
Kapoor LD 1990 CRC Handbook of Ayurvedic medicinal plants.
CRC Press, Boca Raton, p 60
Kasturi M, Ahamed RN, Pathan KM 2002 Ultrastructural changes
induced by leaves of Azadirachta indica (Neem) in the testis of
albino rats. Journal of Basic and Clinical Physiology and
Pharmacology 13(4):311–328
Khosla P, Bhanwra S, Singh J et al 2000 A study of hypoglycaemic
effects of Azadirachta indica (Neem) in normal and alloxan
diabetic rabbits. Indian Journal of Physiology and
Pharmacology 44(1):69–74
Khosla P, Gupta A, Singh J 2002 A study of cardiovascular effects of
Azadirachta indica (Neem) on isolated perfused heart preparations.
Indian Journal of Physiology and Pharmacology
46(2):241–244
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 536–537
Koley KM, Lal J 1994 Pharmacological effects of Azadirachta indica
(Neem) leaf extract on the ECG and blood pressure of rat.
Indian Journal of Physiology and Pharmacology
38(3):223–225
Kumar A, Rao AR, Kimura H 2002 Radiosensitizing effects of
Neem (Azadirachta indica) oil. Phytotherapy Research
16(1):74–77
Luo XD, Wu SH, Ma YB, Wu DG 2000 A new triterpenoid from
Azadirachta indica. Fitoterapia 71(6):668–672
Malathi R, Rajan SS, Gopalakrishnan G, Suresh G 2002
Azadirachtol, a tetranortriterpenoid from Neem kernels. Acta
Crystallographica (Section C) 58(Pt 12):708–710
Mukherjee S, Garg S, Talwar GP 1999 Early post implantation
contraceptive effects of a purified fraction of Neem
(Azadirachta indica) seeds, given orally in rats: possible mechanisms
involved. Journal of Ethnopharmacology
67(3):287–296
Nadkarni KM 1954 The Indian materia medica, with Ayurvedic,
Unani and home remedies, revised and enlarged by A.K.
Nadkarni. Popular Prakashan PVP, Bombay
Njiro SM, Kofi-Tsekpo MW 1999 Effect of an aqueous extract of
Azadirachta indica on the immune response in mice.
Onderstepoort Journal of Veterinary Research 66(1):59–62
Njoku OU, Alumanah EO, Meremikwu CU 2001 Effect of
Azadirachta indica extract on plasma lipid levels in human
malaria. Bollettino Chimico Farmaceutico 140(5):367–370
Pai MR, Acharya LD, Udupa N 2004 Evaluation of antiplaque
activity of Azadirachta indica leaf extract gel: a 6-week clinical
study. Journal of Ethnopharmacology 90(1):99–103
Parida MM, Upadhyay C, Pandya G, Jana AM 2002 Inhibitory
potential of Neem (Azadirachta indica Juss) leaves on dengue
virus type–2 replication. Journal of Ethnopharmacology 79(2):
273–278
Parshad O, Singh P, Gardner M et al 1994 Effect of aqueous Neem
(Azadirachta indica) extract on testosterone and other blood
constituents in male rats: a pilot study. West Indian Medical
Journal 43(3):71–74
Sharma PV 2002 Cakradatta: Sanskrit text with English translation.
Chaukhamba, Varanasi p 6, 120, 168, 190, 236, 265,
347, 469, 490
Sharma VP, Ansari MA, Razdan RK 1993 Mosquito repellent action
of Neem (Azadirachta indica) oil. Journal of the American
Mosquito Control Association 9(3):359–360
254 PART 2: A¯ yurvedic materia medica
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 242
Tepsuwan A, Kupradinun P, Kusamran WR 2002 Chemopreventive
potential of Neem flowers on carcinogen-induced rat mammary
and liver carcinogenesis. Asian Pacific Journal of Cancer
Prevention 3(3):231–238
Upadhyay SN, Dhawan S, Garg S, Talwar GP 1992 Immunomodulatory
effects of Neem (Azadirachta indica) oil. International Journal of
Immunopharmacology 14(7):1187–1193
Vanka A, Tandon S, Rao SR et al 2001 The effect of indigenous
Neem (Azadirachta indica) mouth wash on Streptococcus
mutans and lactobacilli growth. Indian Journal of Dental
Research 12(3):133–144
Vietmeyer ND (ed) 1992 Neem: a tree for solving global problems.
National Academy Press, Washington, p 39–59
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1994 Indian
medicinal plants: a compendium of 500 species, vol 1. Orient
Longman, Hyderabad, p 227
Williamson EM (ed) 2002 Major herbs of Ayurveda. Churchill
Livingstone, London, p 57
Nirgun.d.
ı¯ 255
Botany: Nirgun.d.
ı¯ is a large shrub or small tree with
thin grey bark, quadangular branchlets covered with
a fine white hair, which attains a height of about 3 m.
The leaves are oppositely arranged, with three to five
leaflets, the leaflets lanceolate, acute, glabrous above
with a white, fine hair below, the terminal leaflet
longer than the others on a long petiole, 5–10 cm in
length by 1.6–3.2 cm wide, the lateral leaflets on very
short petioles. The bluish purple flowers are borne in
axillary or terminal panicles up to 30 cm long, giving
rise to black globose drupes with four seeds when ripe.
Nirgun.d.
ı¯ is the name given to specimens with
a bluish purple flower; Sinduvara is the name for the
identical plant with a white flower. Nirgun.d.
ı¯ is found
throughout India, in waste areas and along water
courses, extending westwards into Iran and Eastern
Africa, and eastwards into Malaysia and China
(Kirtikar & Basu 1935, Srikanthamurthy 2001,
Warrier et al 1996).
Part used: Whole plant.
Dravygun. a:
Rasa: ka´sa¯ya, tikta, kat.u
Vipa¯ka: laghu
Vı¯rya: us.n.
a
Karma: dı ¯panapa¯cana, kr . mighna, jvaraghna,
chedana, mu¯travirecana, raktaprasa¯dana,
a¯rtavajanana, sandha¯nı ¯ya, vedana¯stha¯pana, caks.us.ya,
romasañjanana, vis.aghna, medhya, rasa¯yana,
va¯takaphahara (leaf), pittahara (flower)
(Srikanthamurthy 2001, Warrier et al 1996).
Constituents: A variety of constituents have been
isolated from the different plants of Nirgun.d.
ı¯, including
an essential oil, flavonoids and triterpenes. The leaf
is reported to contain an essential oil comprising
monoterpenes terpinen-4-ol, p-cymene, -terpineol
and sabinene, and sesquiterpenes -caryophyllene,
globulol, spathulenol, -farnesene and bis[1,
1-dimethyl]methylphenol. Other constituents include
the alkaloids nishidine and hydrocotylene, the
flavonoids casticin, chrysophenol-D, luteolin and
isoorientin, the triterpenoids betulinic acid, ursolic
acid, 3-acetoxyolean-12-en-27-oic acid, 2,3-
dihydroxyoleana-5,12-dien-28-oic acid, 2,-diacetoxyoleana-
5,12-dien-28-oic acid, and 2, 3-
diacetoxy-18-hydroxyoleana-5,12-dien-28-oic acid,
-sitosterol, the aliphatic alcohol n-hentriacontanol,
and p-hydroxybenzoic acid (Chandramu et al 2003,
Chawla et al 1992, Shafi et al 1998, Yoganarasimhan
2000).
Medical research:
In vitro: antibacterial (Perumal et al 1998),
antivenom (Alam & Gomes 2003).
In vivo: CNS-depressant, analgesic, anticonvulsant
(Gupta et al 1999); hepatoprotective (Avadhoot
& Rana 1991); anti-inflammatory (Jana et al
1999); anti-allergenic (Nair & Saraf 1995); insect
repellent (Hebbalkar et al 1992); antivenom (Alam
& Gomes 2003); antifertility (Bhargava et al 1989).
 





Om Tat Sat
                                                        
(Continued...) 


(My humble salutations to   Sreeman Todd Caldecott, Elsevier’s Health Sciences and others other eminent medical scholars and doctors   for the collection)

0 comments:

Post a Comment